 SALT LAKE CITY, March 2, 2022 PRNewswire -- Recursion NASDAQ: RXRX, the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following upcoming investor conferences: KeyBanc Capital Markets Emerging Technology Summit March 8 through March 9, 2022 SVB Leerink Mountain Meeting March 20 through March 23, 2022 Webcasts may be found in the investor section of the Recursion website at About Recursion Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. 